PNPLA3 and hepatocellular carcinoma: This study aimed to evaluate the impact of the PNPLA3 polymorphism on the risk of HCC development in CHC patients in Brazil.<h4>Methods</h4>This retrospective case-control study included 235 CHC patients with advanced fibrosis, 119 with HCC, and 116 without HCC.